Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06872723 · ClinicalTrials.gov registry record

CPRIT: Patient Adherence to Lung Cancer Screening

A clinical trial of Lung Cancer Screening, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
340
Enrollment target
1
Study location

NCT06872723 is a study of Lung Cancer Screening that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 340 participants, below the 481-participant average among 7 other Lung Cancer Screening trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06872723, a study of Lung Cancer Screening, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
340 participants
Enrollment target
1
Study location

Study Summary

To understand participants' barriers to lung cancer screening and their experience with scheduling lung cancer screening.

Conditions Studied

Interventions

  • BEHAVIORAL Lung Cancer Screening

Study Locations (1)

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 340 participants
Start Date 2025-03-21
Est. Completion 2031-02-28

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT06872723

The ClinicalTrials.gov registry entry for NCT06872723 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 340 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 481-participant average among 7 other Lung Cancer Screening trials with a reported enrollment target (29% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which Lung Cancer Screening is the first listed.

NCT06872723 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06872723 about?

NCT06872723 is a clinical study titled "CPRIT: Patient Adherence to Lung Cancer Screening". To understand participants' barriers to lung cancer screening and their experience with scheduling lung cancer screening.

What is the current status of trial NCT06872723?

This trial is currently recruiting. The enrollment target is 340 participants. The study started on 2025-03-21. Estimated completion is 2031-02-28.

What conditions does trial NCT06872723 study?

This clinical trial studies the following conditions: Lung Cancer Screening.

What interventions are being tested in trial NCT06872723?

The interventions under investigation include: Lung Cancer Screening (BEHAVIORAL).

Who is sponsoring clinical trial NCT06872723?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06872723 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.